The digital, automated, high-throughput, multi-omic platform covers all aspects of the omics-cascade, from genomics to metabolomics, combining mass spectrometry (MS) and genomic sequencing (NGS) techniques to enforce their potential in deciphering key molecular changes following host-pathogen interaction, disease progression, and drug treatment, to assist and guide biomedical and pharmaceutical research in pandemic events.